Australian-New Zealand Clinical Trial: A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of CBT-248 in Healthy Adult Participants

Australia, Oct. 16 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of CBT-248 in Healthy Adult Participants’. The following are the other relevant details related to the trial:

Trial ID: 392689

Submit Date: 9/25/26 9:58

Study Type: Interventional

Intervention: This is a single-site, randomised, double-blind, placebo-controlled, Phase 1 single ascending dose study to investigate the safety, tolerability, and pharmacokinetics of CBT-248 in healthy adult volunteers. CBT-248 is an oral vegetable (cellulose) capsule and will be administered as a single dose under fasted conditions. A total of 24 healthy ...